Phase II trial of dolastatin-10 in patients with advanced breast cancer

By Perez Edith   Hillman David   Fishkin Paul   Krook James   Tan Winston   Kuriakose Phillip   Alberts Steven   Dakhil Shaker  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 257-261

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

By Fury Matthew   Zahalsky Andrew   Wong Richard   Venkatraman Ennapadam   Lis Eric   Hann Lucy   Aliff Timothy   Gerald William   Fleisher Martin   Pfister David  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

By Nimeiri Halla   Singh Deepti   Kasza Kristen   Taber David   Ansari Rafat   Vokes Everett   Kindler Hedy  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 854-858

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Phase II Clinical Trials

By    

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers

By Ciuleanu T.   Diculescu M.   Hoepffner N.   Trojan J.   Sailer V.   Zalupski M.   Herrmann T.   Roth A.   Chick J.   Brock K.   Albert D.   Philip P.  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 385-390

Springer Publishing Company

Access to resources Recommend Favorite